Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
Thursday, February 20, 2020Five Prime Therapeutics Inc a clinicalstage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers today announced a global license agreement with Seattle Genetics Inc to develop and commercializ...
EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19
Wednesday, February 19, 2020EastGate Biotech Corp a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type diabetes announced today that the company along with its Joint Venture Partner EastG...
M8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil
Wednesday, February 19, 2020M Pharmaceuticals and Vectans Pharma announced they have signed an exclusive licensing agreement whereby m will have the rights to register and commercialize Loramyc miconazole for Mexico and Brazil Loramyc is an antifungal agent administered as a mu...
Novartis receives EC Approval for Beovu®, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide
Tuesday, February 18, 2020Novartis announced the European Commission EC has approved Beovu brolucizumab injection for the treatment of wet agerelated macular degeneration AMD Beovu is the first ECapproved antiVEGF treatment to demonstrate superior resolution of retinal fluid...
PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application
Monday, February 17, 2020PharmaMar and Jazz Pharmaceuticals plc announce that the US Food and Drug Administration FDA accepted for filing with Priority Review the New Drug Application NDA seeking accelerated approval for lurbinectedin for the treatment of patients with Small...
Epizyme Announces FDA Acceptance of New Drug Application for Filing with Priority Review for TAZVERIK™ (tazemetostat) for the Treatment of Follicular Lymphoma
Saturday, February 15, 2020Epizyme Inc a fully integrated commercialstage biopharmaceutical company developing novel epigenetic therapies today announced that the US Food and Drug Administration FDA has accepted for filing the companys New Drug Application NDA for the accelera...
FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning
Friday, February 14, 2020Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced that its RiVax heat stable ricin toxin vaccine development program for preve...
WPD Pharmaceuticals to Conduct Clinical Trials in Pediatric Brain Tumors Through Collaboration With CNS Pharmaceuticals
Thursday, February 13, 2020WPD Pharmaceuticals Inc a clinical stage pharmaceutical company is pleased to announce its plan to initiate a Phase I clinical trial for Berubicin in pediatric brain cancer in Poland in collaboration with CNS Pharmaceuticals Inc a biotechnology compa...
OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico
Thursday, February 13, 2020OSE Immunotherapeutics announced a new collaboration agreement with deep technology innovative startup MAbSilico located in Tours France to use artificial intelligence AIbased solutions for therapeutic antibody drug development
Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program
Wednesday, February 12, 2020Advaxis Inc a clinicalstage biotechnology company focused on the development and commercialization of immunotherapy products and Personalis Inc Nasdaq PSNL a leader in advanced genomics for cancer today announced a collaboration to leverage Personali...
